DOI: 10.4244/EIJV9I2A47

Percutaneous treatment of paravalvular leaks after transcatheter aortic valve implantation with the CoreValve self-expanding bioprosthesis

Francesco Saia*, MD, PhD; Cinzia Marrozzini, MD; Carolina Moretti, MD; Barbara Bordoni, MD; Cristina Ciuca, MD; Antonio Marzocchi, MD

Mild-to-moderate aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) is common and often clinically silent. Higher-degree AR may occur, with significant haemodynamic and clinical consequences. Treatment of this condition is challenging and there are no evidence-based therapeutic options. This image illustrates the successful percutaneous management of clinically relevant paravalvular leaks (PVL) after implantation of the CoreValve bioprosthesis (Medtronic, Minneapolis, MN, USA) with the use of vascular plug devices.

Conflict of interest statement

The authors report no financial relationships or conflicts of interest regarding the content herein.

Figure 1. Examples of successful percutaneous closure of severe paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) using two different Amplatzer™ vascular plug (AVP) devices (St. Jude Medical, St. Paul, MN, USA). A) The Amplatzer™ Vascular Plug 4. B) The frame of the bioprosthesis was crossed using an Amplatz Left diagnostic catheter, with the help of a hydrophilic wire. C) Catheter exchange into the left ventricle was performed with a 260 cm hydrophilic wire, and a 6 mm device was advanced through a 6 Fr multipurpose PCI catheter. The distal part of the AVP4 device is visible (arrow). D) Position of the device across the valve frame after its release. E) Closure of a PVL with an AVP2 device (box). The device was released with the proximal disc within the aortic side of the frame and the other two lobes sitting below the severely calcified native valve annulus. F and G) Drawings superimposed on the angiography to highlight the mechanism and the site of aortic regurgitation (F) and the position of the vascular plug (G). The lines show the presence of an angle between the aortic annulus plane (dotted line) and the bioprosthetic valve plane (solid line).

Volume 9 Number 2
Jun 28, 2013
Volume 9 Number 2
View full issue


Key metrics

Trending articles
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
79.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
42

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved